Skip to main content
. 2005 Jan 19;128(3):516–527. doi: 10.1093/brain/awh390

Table 2.

Raw data and information for each patient sample processed

Sample ID
Total no. of oligodendrocytes
Percentage HHV-6 positive
Age and sex
Multiple sclerosis type and duration
Post-mortem interval
Days in fixation
MS 77 LES 1 188 (9/view) 84% F 57 Multiple sclerosis 31 years 28 h 8
MS 77 LES 2 4358 (32/view) 97% F 57 Multiple sclerosis 31 years 28 h 8
MS 80 LES 1221 (24/view) 23% F 71 Secondary progressive MS 35 years 24 h 12
MS 88 NAWM 645 (17/view) 50% F 54 Chronic multiple sclerosis 20 years 22 h 10
MS 88 LES 1536 (29/view) 77% F 54 Chronic multiple sclerosis 20 years 22 h 10
MS 97 NAWM 1640 (29/view) 24% M 55 Multiple sclerosis, details N/A 31 h 14
MS 97 LES 3098 (58/view) 10% M 55 Multiple sclerosis, details N/A 31 h 14
MS 102 NAWM 3773 (47/view) 7% M 73 PPMS 52 years 20 h 26
MS 102 LES 6606 (43/view) 19% M 73 PPMS 52 years 20 h 26
MS 103 NAWM 1107 (26/view) 27% F 77 PPMS 20 years 7 h 24
MS 103 LES 3200 (53/view) 7% F 77 PPMS 20 years 7 h 24
MS 107 LES 1 2750 (28/view) 36% M 38 Progressive RMS 18 years 19 h 22
MS 107 LES 2 216 (14/view) 56% M 38 Progressive RMS 18 years 19 h 22
Control 14 570 (10/view) 12% F 64 COD = myocardial infarction 18 h 22
Control 15 NA 0% M 82 COD = schizophrenia 21 h 18
Control 16 NA 0% M 92 COD = cardiac failure 13 h 10

NA = not applicable; N/A = not available; PPMS = primary progressive multiple sclerosis; RMS = relapsing multiple sclerosis; COD = cause of death